Perspectives on the global response to the novel coronavirus
Scientists work on COVID-19 tests in the Diatropix Lab at Pasteur Institute in Dakar, Senegal.
Scientists work on COVID-19 tests in the Diatropix Lab at the Institut Pasteur de Dakar in Senegal. ©Gates Archive/Carmen Yasmine Abd Ali

Collaborating against COVID

The pandemic upended the world and challenged us all. We share the story of how the Gates Foundation responded, and how investments in global health can pay off in crisis.
Since January 2020, the Bill & Melinda Gates Foundation has committed more than US$2 billion to the global COVID-19 response.
Our funding to address COVID-19

In the face of this unprecedented challenge, we added new funds and reallocated existing funds to slow the transmission of COVID-19, support the development and deployment of life-saving tools, strengthen regional response, and mitigate the damage for communities.

Bill Gates, Anita Zaidi, Keith Klugman, and Lynda Stuart meet over a working dinner
Reflections on the global COVID-19 response

The Gates Foundation invites you to join our co-chairs and global health experts in a series of working dinners. Watch as they share in both a meal and reflections on COVID-19 learnings that might help us prevent the next pandemic.

Latest updates

There is no such thing as a national solution to a global crisis. All countries must work together to end the pandemic and begin rebuilding economies.
Bill Gates and Melinda French Gates
Co-chairs, Bill & Melinda Gates Foundation

Meet our experts

Read more about our work

Vaccine Development & Surveillance

The Vaccine Development & Surveillance team invests in expertise and platform technologies that help us make vaccines faster, better, and cheaper.

Discovery & Translational Sciences

The Discovery & Translational Sciences team invests in the development of new, better, more affordable, and more easily disseminated tools that can have transformational impact on global health and development.

Two women looking at medical notes

Answers to the most frequently asked questions about the foundation's response to COVID-19.

Discover more

Explore additional COVID-19 content